{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:02Z","timestamp":1787002982366,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chordoma is a rare bone malignancy with a high rate of local recurrence and distant metastasis. Although DEP domain-containing protein 1B (DEPDC1B) is implicated in a variety of malignancies, its relationship with chordoma is unclear. In this study, the biological role and molecular mechanism of DEPDC1B in chordoma were explored. The function of DEPDC1B in chordoma cells was clarified through loss-of-function assays in vitro and in vivo. Furthermore, molecular mechanism of DEPDC1B in chordoma cells was recognized by RNA sequencing and Co-Immunoprecipitation (Co-IP) assay. The malignant behaviors of DEPDC1B knockdown chordoma cells was significantly inhibited, which was characterized by reduced proliferation, enhanced apoptosis, and hindered migration. Consistently, decreased expression of DEPDC1B suppressed tumor growth in xenograft mice. Mechanically, DEPDC1B affected the ubiquitination of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) through ubiquitin-conjugating enzyme E2T (UBE2T). Simultaneous downregulation of BIRC5 and DEPDC1B may exacerbate the inhibitory effects of chordoma. Moreover, BIRC5 overexpression reduced the inhibitory effects of DEPDC1B knockdown in chordoma cells. In conclusion, DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5, suggesting that it may be a promising candidate target with potential therapeutic value.<\/jats:p>","DOI":"10.1038\/s41419-021-04026-7","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T02:03:46Z","timestamp":1627610626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5"],"prefix":"10.1038","volume":"12","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"4026_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00292-017-0396-4","volume":"39","author":"G Jundt","year":"2018","unstructured":"Jundt G. [Updates to the WHO classification of bone tumours]. Pathologe. 2018;39:107\u201316.","journal-title":"Pathologe."},{"key":"4026_CR2","unstructured":"Tenny S, Varacallo M. Chordoma. StatPearls. Treasure Island (FL), 2020."},{"key":"4026_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/pbc.23297","volume":"59","author":"MM Al-Rahawan","year":"2012","unstructured":"Al-Rahawan MM, Siebert JD, Mitchell CS, Smith SD. Durable complete response to chemotherapy in an infant with a clival chordoma. Pediatr Blood Cancer. 2012;59:323\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"4026_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.21037\/jss.2019.09.01","volume":"5","author":"N Yamamoto","year":"2019","unstructured":"Yamamoto N, Tsuchiya H. Treatment of chordoma-where is it going? J Spine Surg. 2019;5:387\u20139.","journal-title":"J Spine Surg."},{"key":"4026_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/CCO.0000000000000502","volume":"31","author":"AM Frezza","year":"2019","unstructured":"Frezza AM, Botta L, Trama A, Dei Tos AP, Stacchiotti S. Chordoma: update on disease, epidemiology, biology and medical therapies. Curr Opin Oncol. 2019;31:114\u201320.","journal-title":"Curr Opin Oncol."},{"key":"4026_CR6","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S1470-2045(11)70337-0","volume":"13","author":"BP Walcott","year":"2012","unstructured":"Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13:e69\u201376.","journal-title":"Lancet Oncol."},{"key":"4026_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/path.1969","volume":"209","author":"S Vujovic","year":"2006","unstructured":"Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J. Pathol. 2006;209:157\u201365.","journal-title":"J. Pathol."},{"key":"4026_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00256-006-0167-4","volume":"36","author":"P O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell P, Tirabosco R, Vujovic S, Bartlett W, Briggs TW, Henderson S, et al. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skelet. Radio. 2007;36:59\u201365.","journal-title":"Skelet. Radio."},{"key":"4026_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fonc.2019.00030","volume":"9","author":"T Meng","year":"2019","unstructured":"Meng T, Jin J, Jiang C, Huang R, Yin H, Song D, et al. Molecular targeted therapy in the treatment of chordoma: a systematic review. Front Oncol. 2019;9:30.","journal-title":"Front Oncol."},{"key":"4026_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrm3791","volume":"15","author":"SV Consonni","year":"2014","unstructured":"Consonni SV, Maurice MM, Bos JL. DEP domains: structurally similar but functionally different. Nat Rev Mol Cell Biol. 2014;15:357\u201362.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4026_CR11","first-page":"29","volume":"19","author":"HE Boudreau","year":"2007","unstructured":"Boudreau HE, Broustas CG, Gokhale PC, Kumar D, Mewani RR, Rone JD, et al. Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation. Int J Mol Med. 2007;19:29\u201339.","journal-title":"Int J Mol Med"},{"key":"4026_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-5793(02)03331-8","volume":"528","author":"J Peck","year":"2002","unstructured":"Peck J, Douglas GT, Wu CH, Burbelo PD. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. 2002;528:27\u201334.","journal-title":"FEBS Lett."},{"key":"4026_CR13","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.1523\/JNEUROSCI.23-32-10175.2003","volume":"23","author":"KA Martemyanov","year":"2003","unstructured":"Martemyanov KA, Lishko PV, Calero N, Keresztes G, Sokolov M, Strissel KJ, et al. The DEP domain determines subcellular targeting of the GTPase activating protein RGS9 in vivo. J Neurosci. 2003;23:10175\u201381.","journal-title":"J Neurosci."},{"key":"4026_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.devcel.2014.09.009","volume":"31","author":"S Marchesi","year":"2014","unstructured":"Marchesi S, Montani F, Deflorian G, D\u2019Antuono R, Cuomo A, Bologna S, et al. DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis. Dev Cell. 2014;31:420\u201333.","journal-title":"Dev Cell"},{"key":"4026_CR15","doi-asserted-by":"publisher","first-page":"e12717","DOI":"10.1111\/cpr.12717","volume":"53","author":"N Figeac","year":"2020","unstructured":"Figeac N, Pruller J, Hofer I, Fortier M, Ortuste Quiroga HP, Banerji CRS, et al. DEPDC1B is a key regulator of myoblast proliferation in mouse and man. Cell Prolif. 2020;53:e12717.","journal-title":"Cell Prolif."},{"key":"4026_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fonc.2019.00262","volume":"9","author":"H Zhao","year":"2019","unstructured":"Zhao H, Yu M, Sui L, Gong B, Zhou B, Chen J, et al. High expression of DEPDC1 promotes malignant phenotypes of breast cancer cells and predicts poor prognosis in patients with breast cancer. Front Oncol. 2019;9:262.","journal-title":"Front Oncol."},{"key":"4026_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.bbrc.2014.06.076","volume":"450","author":"Y Yang","year":"2014","unstructured":"Yang Y, Liu L, Cai J, Wu J, Guan H, Zhu X, et al. DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt\/beta-catenin signaling. Biochem Biophys Res Commun. 2014;450:899\u2013905.","journal-title":"Biochem Biophys Res Commun."},{"key":"4026_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12929-014-0067-1","volume":"21","author":"YF Su","year":"2014","unstructured":"Su YF, Liang CY, Huang CY, Peng CY, Chen CC, Lin MC, et al. A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-independent growth in oral cancer cells that is mediated by Rac1 and ERK. J Biomed Sci. 2014;21:67.","journal-title":"J Biomed Sci."},{"key":"4026_CR19","first-page":"6801","volume":"14","author":"S Bai","year":"2017","unstructured":"Bai S, Chen T, Du T, Chen X, Lai Y, Ma X, et al. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer. Oncol Lett. 2017;14:6801\u20138.","journal-title":"Oncol Lett."},{"key":"4026_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.yexcr.2019.03.021","volume":"379","author":"Y Xu","year":"2019","unstructured":"Xu Y, Sun W, Zheng B, Liu X, Luo Z, Kong Y, et al. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis. Exp Cell Res. 2019;379:48\u201354.","journal-title":"Exp Cell Res"},{"key":"4026_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01404-7","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Guo ZQ, Cao D, Chen Y, Chen J. Knockdown of DEPDC1B inhibits the development of glioblastoma. Cancer Cell Int. 2020;20:310.","journal-title":"Cancer Cell Int"},{"key":"4026_CR22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/OTT.S229055","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang S, Shi W, Hu W, Ma D, Yan D, Yu K, et al. DEP Domain-containing protein 1B (DEPDC1B) promotes migration and invasion in pancreatic cancer through the Rac1\/PAK1-LIMK1-Cofilin1 signaling pathway. Onco Targets Ther. 2020;13:1481\u201396.","journal-title":"Onco Targets Ther."},{"key":"4026_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.191","volume":"10","author":"Z Li","year":"2020","unstructured":"Li Z, Wang Q, Peng S, Yao K, Chen J, Tao Y, et al. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling. Clin Transl Med. 2020;10:e191.","journal-title":"Clin Transl Med"},{"key":"4026_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03190-6","volume":"11","author":"CH Lai","year":"2020","unstructured":"Lai CH, Xu K, Zhou J, Wang M, Zhang W, Liu X, et al. DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1. Cell Death Dis. 2020;11:986.","journal-title":"Cell Death Dis."},{"key":"4026_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.1184","volume":"32","author":"S Scheil","year":"2001","unstructured":"Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M, et al. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer. 2001;32:203\u201311.","journal-title":"Genes Chromosomes Cancer"},{"key":"4026_CR26","first-page":"443","volume":"40","author":"B Rinner","year":"2012","unstructured":"Rinner B, Froehlich EV, Buerger K, Knausz H, Lohberger B, Scheipl S, et al. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1. Int J Oncol. 2012;40:443\u201351.","journal-title":"Int J Oncol."},{"key":"4026_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4939-7033-9_17","volume":"1615","author":"JS Lin","year":"2017","unstructured":"Lin JS, Lai EM. Protein-protein interactions: co-immunoprecipitation. Methods Mol. Biol. 2017;1615:211\u20139.","journal-title":"Methods Mol. Biol."},{"key":"4026_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02705243","volume":"31","author":"D Nandi","year":"2006","unstructured":"Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci. 2006;31:137\u201355.","journal-title":"J Biosci."},{"key":"4026_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-biochem-061516-044859","volume":"86","author":"A Varshavsky","year":"2017","unstructured":"Varshavsky A. The ubiquitin system, autophagy, and regulated protein degradation. Annu Rev Biochem. 2017;86:123\u20138.","journal-title":"Annu Rev Biochem"},{"key":"4026_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11011-019-00508-y","volume":"35","author":"M Nasehi","year":"2020","unstructured":"Nasehi M, Torabinejad S, Hashemi M, Vaseghi S, Zarrindast MR. Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1alpha and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats. Metab Brain Dis. 2020;35:183\u201392.","journal-title":"Metab Brain Dis."},{"key":"4026_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/biof.62","volume":"35","author":"A Chatzigeorgiou","year":"2009","unstructured":"Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E. CD40\/CD40L signaling and its implication in health and disease. Biofactors. 2009;35:474\u201383.","journal-title":"Biofactors."},{"key":"4026_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/A:1021601103096","volume":"8","author":"CG Concannon","year":"2003","unstructured":"Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis. 2003;8:61\u201370.","journal-title":"Apoptosis."},{"key":"4026_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13402-019-00427-1","volume":"42","author":"O Ayachi","year":"2019","unstructured":"Ayachi O, Barlin M, Broxtermann PN, Kashkar H, Mauch C, Zigrino P. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival. Cell Oncol (Dordr.). 2019;42:319\u201329.","journal-title":"Cell Oncol (Dordr.)"},{"key":"4026_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-011-0873-7","volume":"357","author":"B Yan","year":"2011","unstructured":"Yan B. Research progress on Livin protein: an inhibitor of apoptosis. Mol Cell Biochem. 2011;357:39\u201345.","journal-title":"Mol Cell Biochem"},{"key":"4026_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0971-5916.159250","volume":"141","author":"PK Jaiswal","year":"2015","unstructured":"Jaiswal PK, Goel A, Mittal RD. Survivin: a molecular biomarker in cancer. Indian J Med Res. 2015;141:389\u201397.","journal-title":"Indian J Med Res"},{"key":"4026_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/25141","volume":"396","author":"F Li","year":"1998","unstructured":"Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580\u20134.","journal-title":"Nature."},{"key":"4026_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4038\/cmj.v63i3.8714","volume":"63","author":"M Budak","year":"2018","unstructured":"Budak M, Bozkurt C, Cetin SE, Tuncel H. The -31 G\/C promoter gene polymorphism of surviving in Turkish colorectal cancers patients. Ceylon Med J. 2018;63:119\u201323.","journal-title":"Ceylon Med J."},{"key":"4026_CR38","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1523\/JNEUROSCI.1446-05.2005","volume":"25","author":"Y Jiang","year":"2005","unstructured":"Jiang Y, de Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM, et al. Essential role for survivin in early brain development. J Neurosci. 2005;25:6962\u201370.","journal-title":"J Neurosci."},{"key":"4026_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0074-7696(05)47002-3","volume":"247","author":"SP Wheatley","year":"2005","unstructured":"Wheatley SP, McNeish IA. Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev. Cytol. 2005;247:35\u201388.","journal-title":"Int Rev. Cytol."},{"key":"4026_CR40","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2006-06-028068","volume":"109","author":"F Zwerts","year":"2007","unstructured":"Zwerts F, Lupu F, De Vriese A, Pollefeyt S, Moons L, Altura RA, et al. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood. 2007;109:4742\u201352.","journal-title":"Blood."},{"key":"4026_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc2293","volume":"8","author":"DC Altieri","year":"2008","unstructured":"Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8:61\u201370.","journal-title":"Nat Rev Cancer"},{"key":"4026_CR42","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1200\/JCO.1999.17.7.2100","volume":"17","author":"M Monzo","year":"1999","unstructured":"Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999;17:2100\u20134.","journal-title":"J Clin Oncol."},{"key":"4026_CR43","first-page":"127","volume":"6","author":"K Tanaka","year":"2000","unstructured":"Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6:127\u201334.","journal-title":"Clin Cancer Res"},{"key":"4026_CR44","first-page":"5071","volume":"58","author":"H Kawasaki","year":"1998","unstructured":"Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58:5071\u20134.","journal-title":"Cancer Res"},{"key":"4026_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0","volume":"92","author":"K Satoh","year":"2001","unstructured":"Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001;92:271\u20138.","journal-title":"Cancer"},{"key":"4026_CR46","doi-asserted-by":"publisher","first-page":"e21158","DOI":"10.1097\/MD.0000000000021158","volume":"99","author":"Z Ma","year":"2020","unstructured":"Ma Z, Wang J, Ding L, Chen Y. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis. Med. (Baltim.). 2020;99:e21158.","journal-title":"Med. (Baltim.)"},{"key":"4026_CR47","doi-asserted-by":"crossref","unstructured":"Nakamura N. Ubiquitin System. Int J Mol Sci. 2018;19:1080.","DOI":"10.3390\/ijms19041080"},{"key":"4026_CR48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"4026_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Disco. 2018;17:57\u201378.","journal-title":"Nat Rev Drug Disco."},{"key":"4026_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2020.06.005","volume":"494","author":"H Yin","year":"2020","unstructured":"Yin H, Wang X, Zhang X, Zeng Y, Xu Q, Wang W, et al. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. Cancer Lett. 2020;494:121\u201331.","journal-title":"Cancer Lett."}],"updated-by":[{"DOI":"10.1038\/s41419-022-05095-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04026-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:14:00Z","timestamp":1669954440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04026-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-022-05095-y","URL":"https:\/\/doi.org\/10.1038\/s41419-022-05095-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures involving mice and experimental protocols were approved by the Institutional Animal Care and Use Committees of Shanghai Jiao Tong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"753"}}